NO301643B1 - Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav - Google Patents

Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav Download PDF

Info

Publication number
NO301643B1
NO301643B1 NO912561A NO912561A NO301643B1 NO 301643 B1 NO301643 B1 NO 301643B1 NO 912561 A NO912561 A NO 912561A NO 912561 A NO912561 A NO 912561A NO 301643 B1 NO301643 B1 NO 301643B1
Authority
NO
Norway
Prior art keywords
ws7622a
amino acid
salt
disulfate
see
Prior art date
Application number
NO912561A
Other languages
English (en)
Norwegian (no)
Other versions
NO912561L (no
NO912561D0 (no
Inventor
Shigehiro Takase
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO912561D0 publication Critical patent/NO912561D0/no
Publication of NO912561L publication Critical patent/NO912561L/no
Publication of NO301643B1 publication Critical patent/NO301643B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
NO912561A 1990-06-29 1991-06-28 Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav NO301643B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (3)

Publication Number Publication Date
NO912561D0 NO912561D0 (no) 1991-06-28
NO912561L NO912561L (no) 1991-12-30
NO301643B1 true NO301643B1 (no) 1997-11-24

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912561A NO301643B1 (no) 1990-06-29 1991-06-28 Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav

Country Status (22)

Country Link
US (2) US5292510A (de)
EP (1) EP0465895B1 (de)
JP (1) JP2663763B2 (de)
KR (1) KR100198693B1 (de)
CN (1) CN1073115C (de)
AT (1) ATE138074T1 (de)
AU (1) AU640241B2 (de)
CA (1) CA2045761C (de)
DE (1) DE69119488T2 (de)
DK (1) DK0465895T3 (de)
ES (1) ES2087178T3 (de)
FI (1) FI106554B (de)
GB (1) GB9014546D0 (de)
GR (1) GR3020184T3 (de)
HU (1) HU213398B (de)
IE (1) IE75702B1 (de)
IL (1) IL98394A (de)
NO (1) NO301643B1 (de)
PH (1) PH31239A (de)
PT (1) PT98134B (de)
RU (1) RU2087482C1 (de)
ZA (1) ZA914349B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111013T3 (es) * 1991-06-18 1998-03-01 Fujisawa Pharmaceutical Co Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
IE912047A1 (en) 1992-01-01
KR920000920A (ko) 1992-01-29
AU7939491A (en) 1992-01-09
HU912198D0 (en) 1991-12-30
RU2087482C1 (ru) 1997-08-20
GR3020184T3 (en) 1996-09-30
PT98134B (pt) 1998-12-31
NO912561L (no) 1991-12-30
CN1057655A (zh) 1992-01-08
FI912914L (fi) 1991-12-30
PT98134A (pt) 1992-06-30
US5364624A (en) 1994-11-15
EP0465895A1 (de) 1992-01-15
IL98394A0 (en) 1992-07-15
DE69119488D1 (de) 1996-06-20
ATE138074T1 (de) 1996-06-15
ZA914349B (en) 1992-03-25
JP2663763B2 (ja) 1997-10-15
US5292510A (en) 1994-03-08
CA2045761A1 (en) 1991-12-30
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
IE75702B1 (en) 1997-09-10
AU640241B2 (en) 1993-08-19
FI106554B (fi) 2001-02-28
EP0465895B1 (de) 1996-05-15
FI912914A0 (fi) 1991-06-17
HUT58351A (en) 1992-02-28
GB9014546D0 (en) 1990-08-22
DE69119488T2 (de) 1996-10-02
CN1073115C (zh) 2001-10-17
JPH04279600A (ja) 1992-10-05
NO912561D0 (no) 1991-06-28
KR100198693B1 (ko) 1999-06-15
DK0465895T3 (da) 1996-06-03
PH31239A (en) 1998-06-18
CA2045761C (en) 1999-09-21
ES2087178T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
EP0368349B1 (de) Serin-Analoge von BU-3608-Antibiotika
NO309274B1 (no) Trifluormetylketon-derivater, og preparater derav
KR970003127B1 (ko) Bu-3608 유도체
NO301643B1 (no) Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav
JP3326793B2 (ja) Ｆｒ９０１４５１物質、その製造法およびその用途
US5286649A (en) Antiviral antibiotic BU-3889V
US5098708A (en) Antiviral antibiotic BU-3889V
AU626622B2 (en) New antibiotic n-acetylbenanomicin b, and the production and uses thereof
WO1993004055A2 (en) Compounds used for the inhibition of hiv-protease
EP0157544A2 (de) Antibiotika, deren Herstellung und Benutzung
RU2021280C1 (ru) Способ получения производных соединения ws7622a
US5110960A (en) Antifungal antibiotics
JPH08208475A (ja) 新用途
WO1995018142A1 (en) Wf15604 substances
IL106806A (en) History of amino and N-alkyl of the antibiotic compounds from the complex of UB-8063 and their preparation
JPH06256338A (ja) 抗腫瘍性物質ｂｅ−３４７７６
JPH09221494A (ja) Ｗｓ７２５４５物質
JPS6344598A (ja) 新規なグリコペプチド系抗生物質
MXPA02005278A (en) Antithrombotic compound

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees